Decreased transcription of <i>prs</i> results in decreased growth. by Javiera Norambuena (137228)

Subjects:

Stimulation of Caco-2 cells with IFN-γ decreases claudin-4 expression. by Manigandan Lejeune (458492)

MK-STYX decreases RhoA activation. by Brittany M. Flowers (670483)

“…<p>(<b>A</b>) PC12 cells were transfected with pMT2 or pMT2-FLAG-MK-STYX-FLAG. 24 hr post-transfection cells were stimulated with 100 ng/ml NGF, and lysed at the indicated time points. …”

NG2 knockdown in GBM xenografts increased vascular reabsorption, decreased plasma volume and normalized tumour vasculature. by Jian Wang (5901)

The expression of 5-hmC was decreased in ESCC tissues and cell lines. by Xuejiao Shi (1684186)

Herceptin down-regulates HER2 receptors and decreases HER3 phosphorylation, but it does not decrease HER2 phosphorylation. by Merel Gijsen (234741)

Decrease in vRNA in brain during antiretroviral therapy. by Sonny R. Elizaldi (9684796)

Decreased proliferation in <i>AnxA2</i>kd and <i>AnxA5</i>kd cells. by Damian C. Genetos (325684)

Decrease in circulating iNKT cell activation during regadenoson (RA) infusion into patients with COVID-19. by Joseph Rabin (7399436)

Subjects:

NDRG2 is decreased during LX-2 activation. by Jiandong Yang (196004)

The G215S mutation decreases packaging of N and growth in primary differentiated human bronchial cells. by Hannah C. Kubinski (21213168)

R848 mediated RANTES, but not TNF-α production, is significantly decreased in TRAM^−/− iBMDMs. by Enda Shevlin (628477)

Stx2 and SubAB decrease HGEC viability. by María M. Amaral (439445)

NR4A1 expression does not decrease after inhibition of p38, JNK and Src pathways. by Glenda Eger (636934)

Ethanol intoxication combined with burn injury decreases miRNA155 expression in T cells. by Xiaoling Li (129705)

Impairment of autophagy decreases trimethylation at H3K4 in human monocytes. by Kathrin Buffen (651914)

Decreasing ShcA expression enhances TGF-β-induced Smad signaling. by Baby Periyanayaki Muthusamy (838234)

“…<p>(A) Smad3 and Smad2 activation, assessed by pSmad3 or pSmad2 immunoblotting, in NMuMG cells, transfected with control or ShcA siRNA (siShc-a), in the absence of added TGF-β or in response to 2 ng/ml TGF-β for 30 min. …”

HRMECs treated with SUZ12 siRNA demonstrate increased miR-200b expression, decreased VEGF expression and decreased endothelial branching. by Michael Anthony Ruiz (726055)

“…However, transfection of SUZ12 siRNA significantly reduced endothelial branching compared to HG+control siRNA. [NG+control siRNA = 5mM D-glucose + 100nM control siRNA, HG+control siRNA = 25mM D-glucose + 100nM control siRNA, HG+EZH2 siRNA = 25mM D-glucose + 100nM EZH2 siRNA, HG+SUZ12 siRNA = 25mM + 100nM SUZ12 siRNA; identical letters represent groups that are not significantly different; p < 0.05; n = 6; data expressed as mean ± SEM, normalized to U6 or β-actin and expressed as a fold change of NG+control siRNA].…”

Cytokine dependent decrease in vSMC viability after type I NKT cell activation. by Gijs H. M. van Puijvelde (500345)

Inhibition of the mitochondrial fission decreases mtROS production. by Dong Ma (584680)

Subjects: